FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market!

The penultimate day of the February series F&O expiry saw the benchmark indices painting a picture of optimism, with hues of green dominating the early trades. However, amidst this canvas of positivity, there were pockets of caution, as a majority of sectors dipped into the red.

The company has a ROCE of 29.9 per cent and a ROE of 22.3 per cent.

Are you looking to trade breakout stocks? Checkout this article that lists top stocks that are experiencing a strong positive brreakout.

Are you looking for solid stocks to trade today? Checkout this article that lists top stocks experiencing a solid positive technical setup.

Are you looking for a strong breakout setup? Checkout this article that lists top stocks witnessing a solid positive breakout.

Glenmark Pharmaceuticals Ltd is an innovation-driven global pharmaceutical company with a presence across Specialty, Generics and OTC businesses

BSE Smallcap index significantly underperformed broader markets by sinking 1.67 per cent to close the session at 26,641.21.